Related stocks: Retail-Drug Stores and Proprietary Stores
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
/
Related stocks: Retail-Drug Stores and Proprietary Stores
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
CVS Health Corporation, together with its subsidiaries (collectively, CVS Health, the Company, we, our or us ), is a leading health solutions company building a world of health around every consumer it serves and connecting care so that it works for people wherever they are. As of December 31, 2025, we had approximately 9,000 retail locations, more than 1,000 walk-in and primary care medical cl…
$90.73
$2.53 (-2.71%)
Price from 10 days ago
Operating margin is thin at 1.16%. Limited cushion if revenue slows or costs rise, not the profile of a wide-moat business.
Revenue grew 7.8%, steady but not accelerating.
At 40x earnings, the current multiple leaves limited room for execution misses or growth deceleration. Net debt of $70.68B represents 9.1x FCF, leverage limits flexibility.
39.8x earnings, 15.7x FCF. Not cheap, the quality is already reflected in the price. Upside from here requires either margin expansion or growth re-acceleration, not just continuation.
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
$407.90B
▲ +7.8% YoY
Net Income (TTM)
$2.93B
▼ -61.7% YoY
Op. Margin
1.46%
▼ -1.1pp YoY
ROIC
3.44%
▼ -1.7pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
$7.39B
▲ +23.4% YoY
Op. Cash Flow (TTM)
$10.33B
▲ +16.8% YoY
Net Debt
$66.54B
Cash & Equiv.
$11.80B
5Y CAGR: +8.4%
5Y CAGR: -10.3%
Continue Research